PP I induces NSCLC cell death through multiple mechanisms, including the activation of the SAPK/JNK pathway, the suppression of p65 and DNMT1 expression [122], the downregulation of MALAT1, and the inhibition of the suppression of STAT3 phosphorylation [123]. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.